Marc Bloom

CoMind

CoMind is a London based, Neurotechnology start-up developing a next-generation neurosensing platform. Their innovative neurosensing technology will catalyse a new wave of neuroscience and neurology applications within medical devices, ultimately forming a seamless interface to the brain. CoMind's technology is particularly unique, as most devices that have the ability to retrieve these signals are either invasive or come at multi-million dollar expense. Not only are CoMind's devices non-invasive and affordable, but they're also portable and will eventually be wearable, allowing them to become ubiquitous. In the long term, this neurosensing technology will form the foundations for a seamless neural interface that will allow engineers to build applications for the brain. CoMind is backed by leading investors such as Octopus Ventures, LocalGlobe and Crane Venture Partners, alongside several high profile angel investors. We are currently hiring for multiple roles: https://comind.jobs.personio.com/.